Tempus AI's (TEM) RNA-based vitro diagnostic device got clearance from the FDA for use. The company reached record highs on Monday's session but pulled back by the closing bell. George Tsilis talks more about the development and why he believes Tempus experienced a pullback.
Market On Close
22 Sep 2025
SHARE